TraceLink, a nine-year-old, software-as-a-service platform for tracking pharmaceuticals and trying to weed out counterfeit prescription drugs in the process, has raised $93 million in Series D funding. Most of the money — $60 million — was used to buy primary shares, with another $33 million used to buy up the shares of previous shareholders. Georgian Partners […]
View More TraceLink, which helps pharma companies trace drugs through the supply chain, just raised $93 millionCategory: tracelink
TraceLink just landed $60 million more to eliminate counterfeit prescription drugs
Just processed by the SEC on this bright Friday afternoon: TraceLink, a software-as-a-service platform for tracking pharmaceuticals and trying to weed out counterfeit prescription drugs in the process, has raised $60 million in Series D funding. The filing shows that 18 firms participated, including, presumably, Goldman Sachs, whose growth equity arm had led the company’s $51.5 million […]
View More TraceLink just landed $60 million more to eliminate counterfeit prescription drugs